Volume 26, Number 10—October 2020
Dispatch
Effect of Nonpharmaceutical Interventions on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, South Korea, 2020
Table
Characteristic | All, no. (%) | Period 1, no. (%)† | Period 2, no. (%)‡ |
---|---|---|---|
Age group, y |
|||
0–19 |
123 (6) |
11 (5) |
112 (6) |
20–39 |
715 (35) |
104 (50) |
611 (34) |
40–59 |
619 (31) |
50 (24) |
569 (31) |
60–79 |
295 (15) |
37 (18) |
258 (14) |
>80y |
50 (3) |
6 (3) |
44 (2) |
Unknown |
221 (11) |
0 |
221(12) |
Sex |
|||
M |
820 (41) |
107 (56) |
713 (39) |
F |
953 (47) |
100 (43) |
853 (47) |
Unknown |
250 (12) |
1 (1) |
249 (14) |
Type of transmission§ |
|||
Local |
892 (44) |
116 (55) |
776 (43) |
Imported from Daegu-Gyeongsangbuk |
155 (8) |
65 (31) |
90 (5) |
Imported from abroad |
552 (27) |
16 (8) |
536 (30) |
Cases occurring in large clusters | 424 (21) | 11 (5) | 413 (23) |
*Assignment to period was based on date of symptom onset. If cases were asymptomatic or date of symptom onset date was not reported, we used the date of case confirmation.
†Jan 20–Feb 23, 2020; n = 208.
‡Feb 24–Apr 21, 2020; n = 1,815.
§Source of infection is provided for all cases; if not identified, we considered the case to have occurred by local transmission.
Page created: June 02, 2020
Page updated: September 17, 2020
Page reviewed: September 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.